XFOR

XFOR

USD

X4 Pharmaceuticals Inc. Common Stock

$3.970-0.030 (-0.750%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$4.000

High

$4.120

Low

$3.940

Volume

0.20M

Company Fundamentals

Market Cap

314.5M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

4.09M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.35Current $3.970High $26.82

Related News

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals with a Buy and raises the price target from $3.5 to $5.

View more
HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5
GlobeNewswire

X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million

BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with rare hematology diseases, today announced the closing of its

View more
X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million
GlobeNewswire

X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering

BOSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with rare hematology diseases, today announced the pricing of its

View more
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering